标题
A prospective real-world analysis of erenumab in refractory chronic migraine
作者
关键词
-
出版物
JOURNAL OF HEADACHE AND PAIN
Volume 21, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-06-03
DOI
10.1186/s10194-020-01127-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study
- (2020) Stewart J Tepper et al. CEPHALALGIA
- Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy
- (2020) Raffaele Ornello et al. JOURNAL OF HEADACHE AND PAIN
- European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
- (2019) Simona Sacco et al. JOURNAL OF HEADACHE AND PAIN
- How to integrate monoclonal antibodies targeting the calcitonin gene-related peptide or its receptor in daily clinical practice
- (2019) Cindy Tiseo et al. JOURNAL OF HEADACHE AND PAIN
- Erenumab in chronic migraine with medication overuse
- (2019) Stewart J. Tepper et al. NEUROLOGY
- Vascular safety of erenumab for migraine prevention
- (2019) David Kudrow et al. NEUROLOGY
- Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study
- (2018) Messoud Ashina et al. CEPHALALGIA
- ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
- (2018) David W Dodick et al. CEPHALALGIA
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
- (2018) CEPHALALGIA
- Erenumab: First Global Approval
- (2018) Anthony Markham DRUGS
- Fremanezumab: First Global Approval
- (2018) Sheridan M. Hoy DRUGS
- Galcanezumab: First Global Approval
- (2018) Yvette N. Lamb DRUGS
- Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study
- (2018) Uwe Reuter et al. LANCET
- Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
- (2017) Stewart Tepper et al. LANCET NEUROLOGY
- A Controlled Trial of Erenumab for Episodic Migraine
- (2017) Peter J. Goadsby et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adherence to oral migraine-preventive medications among patients with chronic migraine
- (2014) Zsolt Hepp et al. CEPHALALGIA
- Refractory chronic migraine: a Consensus Statement on clinical definition from the European Headache Federation
- (2014) Paolo Martelletti et al. JOURNAL OF HEADACHE AND PAIN
- Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS)
- (2012) L. M. Bloudek et al. JOURNAL OF HEADACHE AND PAIN
- Refractory migraine in a headache clinic population
- (2011) Pablo Irimia et al. BMC Neurology
- Chronic Migraine: Epidemiology and Disease Burden
- (2010) Aubrey N. Manack et al. Current Pain and Headache Reports
- Global prevalence of chronic migraine: A systematic review
- (2009) JL Natoli et al. CEPHALALGIA
- Guidelines for Controlled Trials of Prophylactic Treatment of Chronic Migraine in Adults
- (2008) S Silberstein et al. CEPHALALGIA
- Defining Refractory Migraine and Refractory Chronic Migraine: Proposed Criteria From the Refractory Headache Special Interest Section of the American Headache Society
- (2008) Elliott A. Schulman et al. HEADACHE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search